SCHEMBL6205988

SCHEMBL6205988

CC(C)(C)OC(=O)C1(S(=O)(=O)c2ccc(-c3ccc(C(F)(F)F)cn3)s2)CCOCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 4/20 0.38
MMP3 P08254 4/20 0.38
MMP9 P14780 4/20 0.38
MMP8 P22894 4/20 0.38
MMP13 P45452 4/20 0.38
MMP14 P50281 2/20 0.38
MMP1 P03956 2/20 0.38
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
PKM P14618 1/20 0.35
CYP2C19 P33261 1/20 0.35
SCN9A Q15858 2/20 0.33
SCN10A Q9Y5Y9 1/20 0.33
P2RY14 Q15391 1/20 0.33
TRPA1 O75762 1/20 0.33
KIF11 P52732 1/20 0.33
MMP7 P09237 1/20 0.33
PDE2A O00408 2/20 0.33
PDE10A Q9Y233 2/20 0.33
GCK P35557 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6227798 0.87 MMP2 (0.40) MMP2MMP3MMP9MMP8MMP13
SCHEMBL6206695 0.87 DGAT1 (0.37) MMP2MMP3MMP9MMP8MMP13
SCHEMBL6206551 0.85 MMP13 (0.32) MMP2MMP3MMP9MMP8MMP13
SCHEMBL8312448 0.84 MMP13 (0.53) MMP2MMP3MMP9MMP8MMP13
Hydrochloric Acid SCHEMBL6206150 0.83 MMP13 (0.52) MMP2MMP3MMP9MMP8MMP13
SCHEMBL8321170 0.83 MMP1 (0.31) MMP2MMP3MMP9MMP8MMP13
SCHEMBL6228007 0.77 MMP2 (0.39) MMP2MMP3MMP9MMP8MMP13
SCHEMBL6228296 0.76 CYP3A4 (0.43) MMP2MMP3MMP9MMP8MMP13
SCHEMBL6231646 0.75 MMP9 (0.38) MMP2MMP3MMP9MMP8MMP13
SCHEMBL6207339 0.74 MMP13 (0.49) MMP2MMP3MMP9MMP8MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1565459-A2 HETEROARYLSULFONYLMETHYL HYDROXAMIC ACIDS AND AMIDES AND THEIR USE AS PROTEASE INHIBITORS Pharmacia Corporation (US) 2005-08-24 EP disclosed
US-20040142979-A1 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors PHARMACIA CORPORATION 2004-07-22 US disclosed
WO-2004048368-A2 HETEROARYLSULFONYLMETHYL HYDROXAMIC ACIDS AND AMIDES AND THEIR USE AS PROTEASE INHIBITORS PHARMACIA CORPORATION (US) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142979-A1 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors MMP3, MMP13, MMP10 MMP2 6/4885MMP3 1/4885MMP9 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.